Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Hypericin

    DEVELOPMENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Soligenix Manufactures Synthetic Hypericin at Sterling Pharma
    Soligenix Manufactures Synthetic Hypericin at Sterling Pharma

    01 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-announces-synthetic-hypericin-successfully-manufactured-at-sterling-pharma-solutions-302495267.html

    PR NEWSWIRE
    01 Jul 2025
    Share Share
    HyBryte™ Clinical Results Show Continued Post-Treatment Improvement
    HyBryte™ Clinical Results Show Continued Post-Treatment Improvement

    02 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hybryte-clinical-results-demonstrate-continued-improvement-post-treatment-302317457.html

    PR NEWSWIRE
    02 Dec 2024
    Share Share
    Expanded HyBryte Shows Positive Results In Early-Stage Lymphoma
    Expanded HyBryte Shows Positive Results In Early-Stage Lymphoma

    09 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/expanded-hybryte-treatment-demonstrating-positive-outcomes-in-early-stage-cutaneous-t-cell-lymphoma-302190262.html

    PR NEWSWIRE
    09 Jul 2024
    Share Share
    Soligenix stock sinks as FDA refuses lymphoma application
    Soligenix stock sinks as FDA refuses lymphoma application

    15 Feb 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/soligenxs-stock-sinks-36-after-fda-refuses-consider-lymphoma-therapy-application

    James Waldron FIERCE BIOTECH
    15 Feb 2023
    Share Share
    Soligenix opens patient enrolment for Phase IIa trial of psoriasis therapy
    Soligenix opens patient enrolment for Phase IIa trial of psoriasis therapy

    19 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/soligenix-patient-enrolment-trial-psoriasis/

    CLINICALTRIALSARENA
    19 Dec 2022
    Share Share
    Soligenix opens patient enrolment for Phase IIa trial of psoriasis therapy
    Soligenix opens patient enrolment for Phase IIa trial of psoriasis therapy

    19 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/soligenix-patient-enrolment-trial-psoriasis/

    CLINICALTRIALSARENA
    19 Dec 2022
    Share Share